Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur Respir J ; 38(3): 672-8, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20847076

RESUMEN

The objective of this study was to determine whether genetic polymorphisms in enzymes that metabolise oxidative agents modify the individual susceptibility to developing asbestos and smoking-related pleuropulmonary changes. Nine polymorphisms of six genes (EPHX1, GSTM1, GSTM3, GSTP1, GSTT1 and NAT2) were genotyped from 1,008 Finnish asbestos-exposed workers. The genotype data were compared to signs of lung fibrosis and pleural thickenings, as well as with total lung capacity, single-breath diffusing capacity of the lung for carbon monoxide (D(L,CO)) and specific diffusing capacity (expressed as D(L,CO) per unit of alveolar volume (V(A))). The GSTT1 deletion polymorphism was associated with fibrotic changes (p=0.003), and decreased D(L,CO) (p=0.02) and D(L,CO)/V(A) (p=0.002), and the GSTM1 deletion polymorphism was associated with the greatest thickness of pleural plaques (p=0.009). On further analysis, the GSTT1 null genotype was found to pose over a three-fold risk for severe fibrotic changes (OR 3.12, 95% CI 1.51-6.43), and around two-fold risks for decreased D(L,CO) (OR 1.77, 95% CI 1.06-2.95) and D(L,CO)/V(A) (OR 2.37, 95% CI 1.33-4.23). In addition, the GSTM1 null genotype showed an elevated risk (OR 1.36, 95% CI 1.03-1.80) for thicker pleural plaques. Our data suggest that inherited detoxification capacity may affect the development and severity of asbestos and smoking-related nonmalignant pulmonary changes.


Asunto(s)
Amianto/toxicidad , Predisposición Genética a la Enfermedad , Enfermedades Pulmonares/inducido químicamente , Enfermedades Pulmonares/genética , Fibrosis Pulmonar/inducido químicamente , Fibrosis Pulmonar/genética , Anciano , Femenino , Fibrosis , Eliminación de Gen , Genotipo , Glutatión Transferasa/genética , Humanos , Pulmón/patología , Enfermedades Pulmonares/diagnóstico , Masculino , Persona de Mediana Edad , Exposición Profesional , Polimorfismo Genético , Fibrosis Pulmonar/diagnóstico , Control de Calidad , Factores de Riesgo , Xenobióticos/uso terapéutico
2.
Nucleic Acids Res ; 34(11): 3288-98, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16820529

RESUMEN

Histone acetylation plays a key role in the regulation of gene expression. The chromatin structure and accessibility of genes to transcription factors is regulated by enzymes that acetylate and deacetylate histones. The Sin3A corepressor complex recruits histone deacetylases and in many cases represses transcription. Here, we report that SAP30L, a close homolog of Sin3-associated protein 30 (SAP30), interacts with several components of the Sin3A corepressor complex. We show that it binds to the PAH3/HID (Paired Amphipathic Helix 3/Histone deacetylase Interacting Domain) region of mouse Sin3A with residues 120-140 in the C-terminal part of the protein. We provide evidence that SAP30L induces transcriptional repression, possibly via recruitment of Sin3A and histone deacetylases. Finally, we characterize a functional nucleolar localization signal in SAP30L and show that SAP30L and SAP30 are able to target Sin3A to the nucleolus.


Asunto(s)
Nucléolo Celular/metabolismo , Proteínas Nucleares/metabolismo , Proteínas Represoras/metabolismo , Animales , Línea Celular , Nucléolo Celular/química , Silenciador del Gen , Histona Desacetilasas/metabolismo , Humanos , Ratones , Proteínas Nucleares/análisis , Proteínas Nucleares/química , Señales de Clasificación de Proteína , Transporte de Proteínas , Complejo Correpresor Histona Desacetilasa y Sin3
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA